AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12609569 — intervention group
Group type: EXPERIMENTAL
Intervention: Subset multivariate analyses for extensive-stage disease (ED-SCLC)
Number of subjects: 436
Study 12609569 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation analysis
Number of subjects: 436
Study 10503752 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate ingestion (4 kcal x kg(-1) oral carbohydrate beverage)
Number of subjects: 15
Study 9197016 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg/day
Number of subjects: 152
Study 9197016 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study 9197016 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 152
Study 9197016 — intervention group
Group type: COMPARATOR
Intervention: Acebutolol
Number of subjects: 152
Study 1922863 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine 40 mg P.O. the evening before surgery
Number of subjects: 3
Study 1922863 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 300 mg P.O. the evening before surgery
Number of subjects: 3
Study 1922863 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 300 mg I.M. 90 min before induction of anaesthesia
Number of subjects: 3
Study 1922863 — intervention group
Group type: COMPARATOR
Intervention: No drug with H2‐antagonist effect
Number of subjects: 3
Study 6128231 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam 0.5 mg
Number of subjects: 9
Study 6128231 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam 1 mg
Number of subjects: 9
Study 6128231 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 31735161 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 100
Study 31735161 — intervention group
Group type: COMPARATOR
Intervention: Beta-agonists
Number of subjects: 100
Study 29771804 — intervention group
Group type: EXPERIMENTAL
Intervention: Preemptive analgesia (oral acetaminophen and gabapentin followed by intravenous ketamine and dexamethasone)
Number of subjects: 61
Study 29771804 — intervention group
Group type: COMPARATOR
Intervention: Control (oral placebos)
Number of subjects: 61
Study 26406550 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-guided (125)I brachytherapy (group A)
Number of subjects: 72
Study 26406550 — intervention group
Group type: COMPARATOR
Intervention: Symptomatic and supportive treatments (group B)
Number of subjects: 72
Study 24485467 — intervention group
Group type: EXPERIMENTAL
Intervention: Real 1-Hz rTMS
Number of subjects: 24
Study 24485467 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 24
Study 22295819 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint sticking therapy in dog days (group A)
Number of subjects: 55
Study 22295819 — intervention group
Group type: COMPARATOR
Intervention: Acupoint sticking therapy in non-dog days (group B)
Number of subjects: 55
Study 20972736 — intervention group
Group type: EXPERIMENTAL
Intervention: Gliclazide plus metformin (GLIMET)
Number of subjects: 47
Study 20972736 — intervention group
Group type: COMPARATOR
Intervention: Metformin alone (MET)
Number of subjects: 47
Study 17110073 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy-based formulation containing pure soy standardized extract of isoflavones
Number of subjects: 12
Study 17110073 — intervention group
Group type: COMPARATOR
Intervention: Soy-based formulation containing soy flour in addition to the standardized extract of isoflavones
Number of subjects: 12
Study 17110073 — intervention group
Group type: EXPERIMENTAL
Intervention: Equol producers
Number of subjects: 12
Study 17110073 — intervention group
Group type: COMPARATOR
Intervention: Equol non-producers
Number of subjects: 12
Study 17110073 — intervention group
Group type: EXPERIMENTAL
Intervention: Equol producers with equol excretion added to daidzein excretion
Number of subjects: 12
Study 15677794 — intervention group
Group type: EXPERIMENTAL
Intervention: Repaglinide (1 mg twice a day)
Number of subjects: 16
Study 15677794 — intervention group
Group type: COMPARATOR
Intervention: Glibenclamide (5 mg twice a day)
Number of subjects: 16
Study 12448341 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymeric diet (PD)
Number of subjects: 46
Study 12448341 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymeric diet (PD) plus zidovudine
Number of subjects: 46
Study 12448341 — intervention group
Group type: COMPARATOR
Intervention: Regular foods (RF)
Number of subjects: 46
Study 12448341 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (PD and RF)
Number of subjects: 46
Study 10437877 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg twice daily
Number of subjects: 1
Study 8533735 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage hypnosis show
Number of subjects: 205
Study 8533735 — intervention group
Group type: EXPERIMENTAL
Intervention: Public lecture on hypnosis
Number of subjects: 205
Study 8533735 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 205
Study 2270941 — intervention group
Group type: EXPERIMENTAL
Intervention: Human isophane insulin
Number of subjects: 52
Study 2270941 — intervention group
Group type: COMPARATOR
Intervention: Lente insulin
Number of subjects: 52
Study 7022778 — intervention group
Group type: EXPERIMENTAL
Intervention: Day-case surgery
Number of subjects: 138
Study 7022778 — intervention group
Group type: COMPARATOR
Intervention: Inpatient surgery
Number of subjects: 138
Study 31814522 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral stimulation protocol (10 minutes)
Number of subjects: 47
Study 31814522 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 47
Study 30704534 — intervention group
Group type: EXPERIMENTAL
Intervention: ProHEAD online intervention
Number of subjects: 1500
Study 30704534 — intervention group
Group type: COMPARATOR
Intervention: Control condition (recommendation to seek help and online information)
Number of subjects: 1500
Study 27761668 — intervention group
Group type: EXPERIMENTAL
Intervention: Extraoral infrared light therapy for 20 min daily with at least 80% compliance (n=20)
Number of subjects: 40
Study 27761668 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=20)
Number of subjects: 40
Study 26362959 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol-codeine phosphate (300 mg + 30 mg)
Number of subjects: 64
Study 26362959 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen sodium-codeine phosphate (550 mg + 30 mg)
Number of subjects: 64
Study 26362959 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 64
Study 22672359 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate treatment group (n=14)
Number of subjects: 27
Study 22672359 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment group (n=13)
Number of subjects: 27
Study 21720655 — intervention group
Group type: EXPERIMENTAL
Intervention: Pimecrolimus cream 1% applied twice daily
Number of subjects: 20
Study 21720655 — intervention group
Group type: COMPARATOR
Intervention: Topical medical device cream applied three times daily
Number of subjects: 20
Study 19179127 — intervention group
Group type: EXPERIMENTAL
Intervention: Bismuth 240 mg bis in die for 14 days combined with amoxicillin 1g plus metronidazole 250 mg tris in die for the first week
Number of subjects: 108
Study 19179127 — intervention group
Group type: COMPARATOR
Intervention: Lansoprazole 30 mg once a day for 14 days combined with amoxicillin 1g plus metronidazole 250 mg tris in die for the first week
Number of subjects: 108
Study 16838877 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol candies distributed three times during the school day
Number of subjects: 145
Study 16838877 — intervention group
Group type: COMPARATOR
Intervention: Xylitol candies
Number of subjects: 145
Study 12810938 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular triamcinolone hexacetonide (TH)
Number of subjects: 85
Study 12810938 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular triamcinolone acetonide (TA)
Number of subjects: 85
Study 10709370 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling by a pharmacy officer
Number of subjects: 43
Study 10709370 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic interventions initiated by the pharmacy officer
Number of subjects: 43
Study 8598434 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet only
Number of subjects: 127
Study 8598434 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise only
Number of subjects: 127
Study 8598434 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of diet and exercise
Number of subjects: 127
Study 1390616 — intervention group
Group type: EXPERIMENTAL
Intervention: Rural Mexican Diet (RMD)
Number of subjects: 16
Study 1390616 — intervention group
Group type: COMPARATOR
Intervention: Urban Mexican Diet (UMD)
Number of subjects: 16
Study 3891436 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical antihistaminics
Number of subjects: 12
Study 3891436 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 30122390 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual anterior short instrumentation and fusion
Number of subjects: 19
Study 30122390 — intervention group
Group type: COMPARATOR
Intervention: Posterior pedicle screw instrumentation and fusion
Number of subjects: 19
Study 30122390 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 19
Study 27520578 — intervention group
Group type: EXPERIMENTAL
Intervention: Matched learning style group (instructors taught according to students' preferred learning style)
Number of subjects: 0
Study 27520578 — intervention group
Group type: COMPARATOR
Intervention: Unmatched learning style group (instructors taught without regard to students' preferred learning style)
Number of subjects: 0
Study 27520578 — intervention group
Group type: EXPERIMENTAL
Intervention: Matched learning style group
Number of subjects: 0
Study 27520578 — intervention group
Group type: COMPARATOR
Intervention: Unmatched learning style group
Number of subjects: 0
Study 26372467 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 120
Study 26372467 — intervention group
Group type: COMPARATOR
Intervention: Patients with asthma
Number of subjects: 120
Study 26372467 — intervention group
Group type: COMPARATOR
Intervention: Patients with mild COPD
Number of subjects: 120
Study 26372467 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with moderate COPD
Number of subjects: 120
Study 26372467 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with severe COPD
Number of subjects: 120
Study 26372467 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with very-severe COPD
Number of subjects: 120
Study 26372467 — intervention group
Group type: EXPERIMENTAL
Intervention: COPD cohort
Number of subjects: 120
Study 26372467 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma cohort
Number of subjects: 120
Study 24183277 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonically activated shears (USS)
Number of subjects: 40
Study 24183277 — intervention group
Group type: COMPARATOR
Intervention: Traditional suture ligatures
Number of subjects: 40
Study 21511454 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led menu driven intervention
Number of subjects: 239
Study 21511454 — intervention group
Group type: EXPERIMENTAL
Intervention: Concordance interview
Number of subjects: 239
Study 21511454 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 239
Study 19151050 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical levobupivacaine 0.75%
Number of subjects: 246
Study 19151050 — intervention group
Group type: COMPARATOR
Intervention: Topical lidocaine 2%
Number of subjects: 246
Study 16025542 — intervention group
Group type: EXPERIMENTAL
Intervention: Model-based approach for estimating MTD
Number of subjects: 0
Study 16025542 — intervention group
Group type: COMPARATOR
Intervention: Traditional 3+3 design
Number of subjects: 0
Study 15054437 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A (VA) supplementation (210 micromol) and deworming (400 mg albendazole) in Group 1 (VA administered > or = 4 months before baseline)
Number of subjects: 131
Study 15054437 — intervention group
Group type: EXPERIMENTAL
Intervention: VA delivered through the public health system in Group 2 (VA administered < or = 1 month before baseline)
Number of subjects: 131
Study 10937309 — intervention group
Group type: EXPERIMENTAL
Intervention: Relative pitch
Number of subjects: 0
Study 10937309 — intervention group
Group type: EXPERIMENTAL
Intervention: Direction of pitch change
Number of subjects: 0
Study 10937309 — intervention group
Group type: EXPERIMENTAL
Intervention: Level of pitch
Number of subjects: 0
Study 10937309 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory display design
Number of subjects: 0
Study 9071556 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% desonide ointment
Number of subjects: 0
Study 9071556 — intervention group
Group type: COMPARATOR
Intervention: 2.5% hydrocortisone ointment
Number of subjects: 0
Study 7527736 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (CAP or modified M-VAC)
Number of subjects: 20
Study 7527736 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (modified M-VAC or MEC)
Number of subjects: 20
Study 7527736 — intervention group
Group type: COMPARATOR
Intervention: Control group (no adjuvant chemotherapy)
Number of subjects: 20
Study 2568246 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 800 mg
Number of subjects: 15
Study 2568246 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg
Number of subjects: 15
Study 2568246 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine 20 mg
Number of subjects: 15
Study 2568246 — intervention group
Group type: EXPERIMENTAL
Intervention: Nizatidine 150 mg
Number of subjects: 15
Study 2568246 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 4391702 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprenolol 100 mg four times daily
Number of subjects: 21
Study 4391702 — intervention group
Group type: COMPARATOR
Intervention: Pentanitrol 30 mg four times daily
Number of subjects: 21
Study 4391702 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 31060125 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimodipine
Number of subjects: 43
Study 31060125 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 43
Study 28688338 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnenolone (50 mg/day)
Number of subjects: 82
Study 28688338 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 26144319 — intervention group
Group type: EXPERIMENTAL
Intervention: Bladder-Rectum Spacer Balloon (BRSB)
Number of subjects: 80
Study 26144319 — intervention group
Group type: COMPARATOR
Intervention: Vaginal Gauze Packing (VGP)
Number of subjects: 80
Study 24262299 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 40
Study 24262299 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 40
Study 23388588 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin 3 mg 30 minutes before bedtime for 6 weeks
Number of subjects: 38
Study 23388588 — intervention group
Group type: COMPARATOR
Intervention: Clonazepam 2 mg at night (with gradual titration over 4 weeks from 0.5 mg)
Number of subjects: 38
Study 20653727 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐0 poliglecaprone‐25
Number of subjects: 52
Study 20653727 — intervention group
Group type: COMPARATOR
Intervention: 6‐0 polypropylene
Number of subjects: 52
Study 20653727 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐0 poliglecaprone‐25 and 6‐0 polypropylene
Number of subjects: 52
Study 19045977 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week Internet-based cognitive behavior therapy program with minimal therapist contact via e-mail and weekly telephone calls of less than 15 min
Number of subjects: 66
Study 19045977 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 66
Study 15949095 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% solution of betamethasone dipropionate (BD)
Number of subjects: 51
Study 15949095 — intervention group
Group type: COMPARATOR
Intervention: Hydrocortisone with oxytetracycline hydrochloride and polymyxin B (HCPB)
Number of subjects: 51
Study 14627440 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflavones tablets
Number of subjects: 853
Study 10571764 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (400 microg)
Number of subjects: 60
Study 9380298 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogens (0.15 or 0.3 or 0.625 mg)
Number of subjects: 132
Study 9380298 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study 8436494 — intervention group
Group type: EXPERIMENTAL
Intervention: Meclofenamate sodium (100mg, two capsules a day for 15 days)
Number of subjects: 20
Study 8436494 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 8436494 — intervention group
Group type: EXPERIMENTAL
Intervention: Meclofenamate sodium
Number of subjects: 20
Study 8436494 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure threshold measurements
Number of subjects: 20
Study 3296154 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacrisert
Number of subjects: 29
Study 3296154 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saccharose crystals)
Number of subjects: 29
Study 28913928 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Coaching (HC)
Number of subjects: 302
Study 28913928 — intervention group
Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 302
Study 27568900 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem nasal spray 1.75 mg
Number of subjects: 36
Study 27568900 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem nasal spray 3.5 mg
Number of subjects: 36
Study 27568900 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem nasal spray 5.0 mg
Number of subjects: 36
Study 27568900 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem nasal spray (1.75 mg, 3.5 mg, 5.0 mg)
Number of subjects: 36
Study 27568900 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem nasal spray
Number of subjects: 36
Study 27568900 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 25099578 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospitals participating in the pay-for-performance program (Advancing Quality)
Number of subjects: 1825518
Study 25099578 — intervention group
Group type: COMPARATOR
Intervention: Control hospitals (not participating in the program)
Number of subjects: 1825518
Study 21735215 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast lifting speed (1.9 s/repetition)
Number of subjects: 13
Study 21735215 — intervention group
Group type: COMPARATOR
Intervention: Slow lifting speed (5.6 s/repetition)
Number of subjects: 13
Study 21735215 — intervention group
Group type: COMPARATOR
Intervention: Medium lifting speed (2.8 s/repetition)
Number of subjects: 13
Study 21735215 — intervention group
Group type: COMPARATOR
Intervention: Ballistic maximum speed
Number of subjects: 13
Study 21735215 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavier conditions (80% 1RM)
Number of subjects: 13
Study 21735215 — intervention group
Group type: COMPARATOR
Intervention: Lighter intensities (40% 1RM)
Number of subjects: 13
Study 21152784 — intervention group
Group type: EXPERIMENTAL
Intervention: cream with Belides, Emblica and Licorice 7%, applied twice a day
Number of subjects: 56
Study 21152784 — intervention group
Group type: COMPARATOR
Intervention: cream with Hydroquinone 2%, used at night
Number of subjects: 56
Study 18777976 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week walking training program
Number of subjects: 0
Study 18777976 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient clinic-based walking program
Number of subjects: 0
Study 18777976 — intervention group
Group type: EXPERIMENTAL
Intervention: Health promotion interventions
Number of subjects: 0
Study 15941541 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed effect model
Number of subjects: 0
Study 15941541 — intervention group
Group type: EXPERIMENTAL
Intervention: Random effect model
Number of subjects: 0
Study 15941541 — intervention group
Group type: EXPERIMENTAL
Intervention: Covariance analysis
Number of subjects: 0
Study 15941541 — intervention group
Group type: EXPERIMENTAL
Intervention: Heterogeneity test (fixed effect model)
Number of subjects: 0
Study 15941541 — intervention group
Group type: EXPERIMENTAL
Intervention: Heterogeneity test (random effect model)
Number of subjects: 0
Study 12151444 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-Controlled Sedation (PCS)
Number of subjects: 106
Study 12151444 — intervention group
Group type: COMPARATOR
Intervention: Physician-Administered Sedation (PAS)
Number of subjects: 106
Study 10554120 — intervention group
Group type: EXPERIMENTAL
Intervention: HBcAg stimulation in group 1 (raised alanine transferase levels)
Number of subjects: 54
Study 10554120 — intervention group
Group type: EXPERIMENTAL
Intervention: HBcAg stimulation in group 1
Number of subjects: 54
Study 10554120 — intervention group
Group type: EXPERIMENTAL
Intervention: HBcAg stimulation in all groups
Number of subjects: 54
Study 10554120 — intervention group
Group type: EXPERIMENTAL
Intervention: HBcAg stimulation in groups 1 and 2
Number of subjects: 54
Study 10554120 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS stimulation in group 1
Number of subjects: 54
Study 10554120 — intervention group
Group type: COMPARATOR
Intervention: HBV antigens or LPS stimulation in children of carrier mothers
Number of subjects: 54
Study 8622041 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol 77-04 (15 cycles of CTX, ADR, PRED, VCR, high-dose MTX, and IT therapy)
Number of subjects: 72
Study 8622041 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol 89-C-41 (high-risk patients received CODOX-M and IVAC; low-risk patients received CODOX-M)
Number of subjects: 72
Study 8622041 — intervention group
Group type: COMPARATOR
Intervention: Granulocyte-macrophage colony-stimulating factor (GM-CSF) in high-risk patients
Number of subjects: 72
Study 8365461 — intervention group
Group type: EXPERIMENTAL
Intervention: Teicoplanin
Number of subjects: 50
Study 8365461 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 50
Study 3780987 — intervention group
Group type: EXPERIMENTAL
Intervention: (modified) radical mastectomy
Number of subjects: 0